TPM1 and TPM4 expression in response to TNFα. by Stuart A. Savill (3129060)

TPM1 and TPM4 expression in response to IL-1α. by Stuart A. Savill (3129060)

TPM1 and TPM4 expression in response to TNFα. by Stuart A. Savill (3129060)

TPM1 and TPM4 expression in response to glucose and insulin. by Stuart A. Savill (3129060)

TPM1 and TPM4 expression in response to IL-1α. by Stuart A. Savill (3129060)

Repeat sampling of individuals with Type 2 diabetes. by Stuart A. Savill (3129060)

Argon-mediated decrease of apoptosis is attenuated following ERK1/2 and TLR inhibition. by Felix Ulbrich (678720)

DLS mGluR1/5 signaling activation in instrumental conditioning and differential behavioral sensitivity to A–O changes with training duration. by Vincent Paget-Blanc (21807763)

Genes whose expression was decreased by 1 mM ouabain by more than 2-fold. by Larisa V. Smolyaninova (3600053)

Individual survey sum scores during follow-up, combined with mean scores and 95% CIs. by A. H. Ayesha Lavell (16734002)

Subjects:

Simulated estimates of number of silicosis cases and annual tuberculosis (TB) cases at cumulative RCS distributions of increasing mean values. by Patrick Howlett (2612374)

Subjects:

Overview of Illumina sequencing data, detected 5mC sites, and SNPs. by Mareike Möller (5548745)

Subjects:

Stroma decreases spheroid size by decreasing cell width. by Karen F. Chambers (224337)

HRQoL by EQ-5D-index and EQ-VAS stratified by gender and county. by Elin Spege (11378261)

Subjects:

Proportion respondents reporting moderate or severe problems on each EQ-5D dimension; %. by Elin Spege (11378261)

Subjects:

Postnatal CDPPB treatment decreased [¹¹C]PBR accumulation in saline-exposed offspring, but not in offspring prenatally exposed to LPS. by Dany Arsenault (229311)

“…Values are expressed as mean ± SEM. Abbreviations: CDPPB, 3-cyano-<i>N</i>-(1,3-diphenyl-1<i>H</i>-pyrazol-5-yl)benzamide; [¹¹C] PBR28, peripheral benzodiazepine receptor 28; Ctx, cortex; Crbl, cerebellum; Hip, hippocampus; Hth, hypothalamus; OB, olfactory bulb; PnD, postnatal day; Str, striatum; W, whole brain. …”

Twenty-four hour monitoring revealed increased interaction and decreased activity during daytime in <i>Cdkl5</i> -/Y mice. by Kosuke Okuda (5150393)

“…The genotype difference during the whole period was not significant (p = 0.791). (B) Mean values in the middle three days. <i>Cdkl5</i> -/Y mice show significant decreases in the number of particles (i) and activity level (ii) during daytime. …”

Combined survival analysis of preoperative serum albumin levels (preAlb) and postoperative decrease in serum albumin (ΔAlb). by Fumihiko Kinoshita (6655172)

Evolution of the rates (per 100,000), Number of inpatients/Total population of the country. by Roberto Rodríguez-Rivas (13514430)

Changes in body weight, fat mass and lean body mass over 5 years after RYGB independent of intervention groups. by Alice Bellicha (3583493)